| Literature DB >> 25380980 |
Michael Oster, Eduard Muráni, Siriluck Ponsuksili, Richard B D'Eath, Simon P Turner, Gary Evans, Ludger Thölking, Esra Kurt, Ronald Klont, Aline Foury, Pierre Mormède, Klaus Wimmers1.
Abstract
BACKGROUND: Brain and immune system are linked in a bi-directional manner. To date, it remained largely unknown why immune components become suppressed, enhanced, or remain unaffected in relation to psychosocial stress. Therefore, we mixed unfamiliar pigs with different levels of aggressiveness. We separated castrated male and female pigs into psychosocially high- and low- stressed animals by skin lesions, plasma cortisol level, and creatine kinase activity obtained from agonistic behaviour associated with regrouping. Peripheral blood mononuclear cells (PBMC) were collected post-mortem and differential gene expression was assessed using the Affymetrix platform (n = 16).Entities:
Mesh:
Substances:
Year: 2014 PMID: 25380980 PMCID: PMC4233077 DOI: 10.1186/1471-2164-15-967
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Experimental design used to analyse transcriptional responses due to different levels of psychosocial stress. The origin and composition of the profiled sampling groups is shown regarding their parental genetics, affiliation to skin lesion group, and resulted stress levels. LR - Landrace; LW – Large White; D – Duroc; P – Pietrain; H – High lesion score; L – Low lesion score; HS – High stress; LS – Low stress.
Phenotype data of the analysed animals
| Parameter | HSF | HSM | LSF | LSM | p-value # |
|---|---|---|---|---|---|
| Skin lesions § | |||||
| Front | 72.0 ± 16.5 | 65.0 ± 22.0 | 7.5 ± 1.3 | 16.0 ± 6.8 | <0.001 |
| Mid | 60.0 ± 23.0 | 45.8 ± 22.5 | 12.8 ± 3.0 | 19.5 ± 11.7 | <0.05 |
| Rear | 28.0 ± 16.9 | 7.8 ± 2.6 | 5.5 ± 1.3 | 8.5 ± 2.5 | >0.10 |
| Total | 160.0 ± 47.9 | 118.5 ± 46.7 | 25.8 ± 3.8 | 44.0 ± 13.2 | <0.01 |
| Creatinekinase (U/l) | 11543.0 ± 3270.5 | 9232.0 ± 1430.8 | 2062.5 ± 356.5 | 2904.5 ± 260.5 | <0.001 |
| Cortisol (ng/ml) | 65.2 ± 8.50 | 72.5 ± 6.3 | 50.7 ± 6.7 | 59.0 ± 7.0 | <0.10 |
Values are displayed as mean ± SEM; n =8; balanced for mixing groups; # effects for stress level but not for sexes; p-value (2 tailed) of a two sample t-test reflecting differences between animals with high stress level and low stress level; § skin lesions in body sections: front (head, neck, shoulders, and front legs), middle (flanks and back), and rear (rump, hind legs, and tail).
Primer used to verify microarray experiments by qPCR
| Gene symbol | Sequence 5' - 3' For | Sequence 5' - 3' Rev | Size (bp) |
|---|---|---|---|
| CCR1 | CATTCCAGAAGATTGGGACAA | TGGCTCCAGGCTCATAGTAGA | 182 |
| CD14 | GAGGTGGCAGAGTTCAAAGAG | CATGGTCGATAAGGTCCTCAA | 196 |
| TLR2 | TAAGTTGAAGACGCTCCCAGA | ACAGGAAGTCACAGGAGCAGA | 167 |
| TLR4 | CTCTGCCTTCACTACAGAGA | TTGAGTCGTCTCCAGAAGAT | 323 |
| TREM1 | GGGAGAGACCCTGAATGTGA | ATCTTCCCCACCTGGACTTTA | 156 |
| HPRT1* | GTGATAGATCCATTCCTATGACT | TGAGAGATCATCTCCACCAATTA | 104 |
| PPIA* | GATTTATGTGCCAGGGTGGT | CTTGGCAGTGCAAATGAAAA | 179 |
| RPL32* | AGCCCAAGATCGTCAAAAAG | TGTTGCTCCCATAACCAATG | 165 |
CCR1 – chemokine (C-C motif) receptor 1; CD14 – CD14 molecule; TLR2 – toll-like receptor 2; TLR4 – toll-like receptor 4; TREM1 – triggering receptor expressed on myeloid cells 1 precursor; HPRT1 – hypoxanthine phosphoribosyltransferase 1; PPIA – peptidylprolylisomerase A (cyclophilin A); RPL32 – ribosomal protein 32; * reference gene.
Figure 2Numbers of probe-sets showing altered mRNA abundances according to stress level and sex. Probe-sets differ between females, but not between male animals. Red and green numbers indicate higher and lower transcript abundances, respectively (e.g. 315 probe-sets showed an increased mRNA abundance in HS-females compared to LS-females).
Ingenuity pathway analysis of transcripts with higher expression between High-stressed females and Low-stressed females
| Canonical pathway | Expression | p-value | Involved genes with altered mRNA abundances | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dendritic cell maturation | HSF > LSF | 6.20E-04 | Gene symbol | CD1D | ICAM1 | IL1B | IL1RN | JAK2 | MYD88 | TLR2 | TLR4 | TNFRSF1A | TNFRSF1B | TRD@ | TYROBP |
| Fold Change | +1.74 | +1.56 | +2.35 | +3.07 | +1.69 | +1.85 | +1.82 | +3.71 | +1.43 | +1.79 | +1.81 | +1.92 | |||
| IL-6 signaling | HSF > LSF | 7.69E-03 | Gene symbol | A2M | CD14 | CSNK2A1 | IL1B | IL1RN | JAK2 | TNFRSF1A | TNFRSF1B | ||||
| Fold Change | +3.00 | +3.89 | +1.38 | +2.35 | +3.07 | +1.69 | +1.43 | +1.79 | |||||||
| IL-8 signaling | HSF > LSF | 4.67E-02 | Gene symbol | GNG10 | ICAM1 | MYL2 | PTGS2 | RHOQ | SRC | TEK | VASP | ||||
| Fold Change | +1.70 | +1.56 | +1.49 | +2.62 | +2.13 | +1.51 | +2.12 | +1.26 | |||||||
| Toll-like receptor signaling | HSF > LSF | 1.83E-02 | Gene symbol | CD14 | LY96 | MYD88 | TLR2 | TLR4 | |||||||
| Fold Change | +3.89 | +1.43 | +1.85 | +1.82 | +3.71 | ||||||||||
| TREM 1 signaling | HSF > LSF | 3.22E-05 | Gene symbol | CASP1 | ICAM1 | IL1B | JAK2 | MYD88 | TLR2 | TLR4 | TREM1 | TYROBP | |||
| Fold Change | +1.70 | +1.56 | +2.35 | +1.69 | +1.85 | +1.82 | +3.71 | +2.80 | +1.92 | ||||||
P-value: significance of association between dataset and IPA according to Benjamini-Hochberg multiple testing correction; Details regarding involved genes were displayed in Additional file 1.
Figure 3Heat-map considering the altered probe-sets (rows) due to the variance component stress level*sex (columns). The clustering revealed HS-females as most different from LS-females and male samples.
Selected transcripts encoding immune receptors
| Gene symbol | Comparison | Microarray | |||
|---|---|---|---|---|---|
| p-value | q-value | Expression | FC | ||
| CCRL2 | Females | <0.05 | <0.25 | HSF > LSF | +2.22 |
| Males | >0.10 | >0.25 | HSM = LSM | +1.02 | |
| CD1D | Females | <0.01 | <0.25 | HSF > LSF | +1.74 |
| Males | >0.10 | >0.25 | HSM = LSM | +1.19 | |
| CD19 | Females | <0.05 | <0.25 | HSF < LSF | -2.70 |
| Males | >0.10 | >0.25 | HSM = LSM | -1.05 | |
| CR2 | Females | <0.01 | <0.25 | HSF < LSF | -3.13 |
| Males | >0.10 | >0.25 | HSM = LSM | +1.01 | |
| CXCR7 | Females | <0.05 | <0.25 | HSF < LSF | -2.83 |
| Males | >0.10 | >0.25 | HSM = LSM | -1.54 | |
| IL13RA1 | Females | <0.01 | <0.25 | HSF > LSF | +2.55 |
| Males | >0.10 | >0.25 | HSM = LSM | +1.04 | |
| IL27RA | Females | <0.01 | <0.25 | HSF < LSF | -1.38 |
| Males | >0.10 | >0.25 | HSM = LSM | +1.04 | |
| IL6R | Females | <0.05 | <0.25 | HSF < LSF | -1.34 |
| Males | >0.10 | >0.25 | HSM = LSM | +1.08 | |
| IL7R | Females | <0.05 | <0.25 | HSF < LSF | -1.84 |
| Males | >0.10 | >0.25 | HSM = LSM | +1.01 | |
| TNFRSF1A | Females | <0.05 | <0.25 | HSF > LSF | +1.43 |
| Males | >0.10 | >0.25 | HSM = LSM | -1.03 | |
| TNFRSF1B | Females | <0.05 | <0.25 | HSF > LSF | +1.79 |
| Males | >0.10 | >0.25 | HSM = LSM | -1.12 | |
| TRAF5 | Females | <0.05 | <0.25 | HSF < LSF | -1.83 |
| Males | >0.10 | >0.25 | HSM = LSM | +1.12 | |
Significance level was set at p <0.05 and q <0.25; CCRL2 – chemokine (C-C motif) receptor-like 2; CD1d – CD1d molecule; CD19 – CD19 molecule; CR2 – complement component receptor 2; CXCR7 – chemokine (C-X-C motif) receptor 7; IL13RA1 – interleukin 13 receptor, alpha 1; IL27RA – interleukin 27 receptor, alpha; IL6R – interleukin 6 receptor; IL7R – interleukin 7 receptor; TNFRSF1A – tumor necrosis factor receptor superfamily, member 1A; TNFRSF1B – tumor necrosis factor receptor superfamily, member 1B; TRAF5 – TNF receptor-associated factor 5; FC – Fold change.
Comparison of microarray and quantitative PCR (qPCR) results for selected transcripts, encoding immune receptors
| Gene symbol | Comparison | Microarray | Real-time PCR # | Correlation ## | |||||
|---|---|---|---|---|---|---|---|---|---|
| p-value | q-value | expression | FC | p-value | expression | FC | coefficient | ||
| CCR1 | Females | <0.05 | <0.25 | HSF > LSF | +2.60 | <0.10 | HSF = LSF | +1.81 | 0.93*** |
| Males | <0.05 | >0.25 | HSM = LSM | +1.75 | >0.10 | HSM = LSM | +1.23 | ||
| CD14 | Females | <0.05 | <0.25 | HSF > LSF | +3.89 | <0.05 | HSF > LSF | +1.88 | 0.87*** |
| Males | <0.05 | >0.25 | HSM = LSM | +2.53 | >0.10 | HSM = LSM | +1.11 | ||
| TLR2 | Females | <0.01 | <0.25 | HSF > LSF | +1.82 | <0.05 | HSF > LSF | +1.34 | 0.87*** |
| Males | <0.05 | >0.25 | HSM = LSM | +1.44 | >0.10 | HSM = LSM | +1.10 | ||
| TLR4 | Females | <0.05 | <0.25 | HSF > LSF | +3.71 | <0.05 | HSF > LSF | +1.82 | 0.88*** |
| Males | <0.10 | >0.25 | HSM = LSM | +1.85 | >0.10 | HSM = LSM | +1.15 | ||
| TREM1 | Females | <0.01 | <0.25 | HSF > LSF | +2.80 | <0.01 | HSF > LSF | +3.51 | 0.90*** |
| Males | <0.01 | >0.25 | HSM = LSM | +2.18 | <0.10 | HSM = LSM | +2.09 | ||
Significance level was set at p <0.05 and q <0.25; FC - Fold change; # Values were calculated by factorial normalization on RPL32, PPIA and HPRT1 expression values; ## correlation of normalized expression values was calculated by Spearman (*** p < 0.0001).